Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Absci Corp (NQ: ABSI )

3.880 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 3.880
Bid (Size) 3.740 (1)
Ask (Size) 3.940 (8)
Prev. Close 3.880
Today's Range 3.880 - 3.880
52wk Range 1.111 - 6.720
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AI-Focused Drug Discovery Stocks +6% Last Week Vs. -8% Previous Week
The AI-powered drug discovery process is expected to grow by a CAGR of 30% between now and 2030 which should result in as many as 50 novel therapies being brought to market by then and generate annual... 
Via Talk Markets
AI-Focused Drug Discovery Stocks Portfolio -8% W/e Sept 6th
The AI-powered drug discovery process is expected to grow by a CAGR of 30% between now and 2030 and should result in as many as 50 novel therapies being brought to market by then and generate annual... 
Via Talk Markets

Performance

YTD
+5.15%
+5.15%
1 Month
-13.59%
-13.59%
3 Month
+26.38%
+26.38%
6 Month
-29.96%
-29.96%
1 Year
+203.12%
+203.12%

More News

Read More
Our AI-Focused Drug Discovery Stocks Portfolio Down 8% In August; Down 6.7% Yesterday Alone!
Via Talk Markets
Topics Economy
Exposures Economy
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Via The Motley Fool
Our AI-Focused Drug Discovery Stocks Portfolio Was Up Almost 7% Last Week
Via Talk Markets
Absci to Participate in Upcoming Investor Conferences
From Absci Corporation
Via GlobeNewswire
ABSI Stock Earnings: Absci Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results
From Absci Corporation
Via GlobeNewswire
AI-Focused Drug Discovery Stocks Portfolio Hit Hard: Down 14% MTD
Via Talk Markets
Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI
From Absci Corporation
Via GlobeNewswire
AI-Focused Drug Discovery Stocks Portfolio Up 7% Last Week; Up 19% MTD
Via Talk Markets
Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD
Via Talk Markets
Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024
From Absci Corporation
Via GlobeNewswire
Corning Increases Sales Forecast, Joins Morphic Holding, Lucid Group And Other Big Stocks Moving Higher On Monday
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Absci Corporation
Via GlobeNewswire
Clinical-Stage BioTech Drug Stocks Declined 13% In June
Via Talk Markets
Cathie Wood's Ark Invest Sells Coinbase Shares As Bitcoin Drops Below Key $62K Level
Via Benzinga
Largest Clinical-Stage BioTech Drug Stocks Declined 6%
Via Talk Markets
AMC Networks, Louisiana-Pacific And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Absci to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit
From Absci Corporation
Via GlobeNewswire
AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week
Via Talk Markets
Cathie Wood-LedArk Invest Cuts Robinhood Holdings Amid Bitcoin Dip, Keeps Selling Moderna Stock — Buys Palantir And AMD Shares
Via Benzinga
Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
From Absci Corporation
Via GlobeNewswire
A $50B AI Drug Discovery Revolution Has Begun - Here Are 6 Stocks To Consider Investing In
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.